NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NEW YORK MEDICAL COLLEGE, LOVELACE BIOMEDICAL RESEARCH INSTITUTE AND WEISSMAN HOOD INSTITUTE OF TOURO UNIVERSITY (FORMERLY MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES) AND THE OPERATIONS OF TRUMADA MANAGEMENT.
THE ACQUISITION OF THE NEW YORK MEDICAL COLLEGE, LOVELACE BIOMEDICAL RESEARCH INSTITUTE, LOVELACE SCIENTIFIC RESOURCES, AND WEISSMAN HOOD INSTITUTE OF TOURO UNIVERSITY (FORMERLY MCLAUGHLIN RESEARCH...
THE ACQUISITION OF THE NEW YORK MEDICAL COLLEGE, LOVELACE BIOMEDICAL RESEARCH INSTITUTE, LOVELACE SCIENTIFIC RESOURCES, AND WEISSMAN HOOD INSTITUTE OF TOURO UNIVERSITY (FORMERLY MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES). FACILITATES AND ACCELERATES THE UNIVERSITY'S STRATEGIC GROWTH, IMPROVES THE QUALITY OF ITS EDUCATIONAL OFFERINGS, EXPANDS RESEARCH AND DEVELOPMENT ACTIVITIES, AND PROVIDES GREATER PROFESSIONAL OPPORTUNITIES FOR STUDENTS. (SEE SCHEDULE O).
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Expenses | $20,150 | $25,844 | -0.2% |
| Net Income | N/A | $-25,844 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ALAN KADISH | PRESIDENT, CEO AND MANAGER | 1.00 |
Officer
Director
|
$0 | $271,255 | $1,335,433 |
| BEN CHOUAKE | TREASURER AND MANAGER | 0.10 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID LICHTENSTEIN | MANAGER | 0.10 |
Director
|
$0 | $0 | $0 |
| MARTIN OLINER | MANAGER | 0.10 |
Director
|
$0 | $0 | $0 |
| ZVI RYZMAN | CHAIRMAN AND MANAGER | 1.00 |
Director
|
$0 | $0 | $0 |
| MELVIN NESS | ASSISTANT TREASURER | 1.00 |
Officer
|
$0 | $17,223 | $457,725 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | $20,150 | $60,370,097 | No data |
| 2023 | No data | $25,844 | $60,082,177 | No data |
| 2022 | No data | $25,852 | $60,082,178 | No data |
| 2021 | No data | $21,901 | $60,080,719 | No data |
| 2020 | No data | $33,054 | $60,080,719 | No data |
| 2019 | No data | $137,065 | $60,081,762 | No data |
| 2018 | No data | $210,245 | $60,080,719 | No data |
Compare NYMC LLC with other nonprofits in New York and across the country.